1.3M views · 87 reactions | Genomic cancer testing can be a crucial step in a patient’s diagnosis and may identify how tumors behave and grow. Genomic cancer tests can identify DNA alterations regardless of a tumor's location in the body. Painting the full picture is the first step in building a treatment plan. Learn more about genomic testing. | Bayer U.S. | Facebook

10+ different types of genomic alterations (or biomarkers) – changes within cancer cells that can determine how the tumor behaves and why it grows – can be found in non-small cell lung cancer including: NTRK*, KRAS, EGFR, ALK, HER2, BRAF, PIK3CA, ROS1, RET, MET, AKT1, NRAS, MAPP2K1. Learn more about how genomic cancer testing may open new doors to treatment options. 溺 *Neurotrophic tyrosine receptor kinase | Bayer U.S. | Facebook

1.3K views · 61 reactions | Newly published research shows that more women with early-stage breast cancer can use a genomic test called the Oncotype DX Breast Recurrence Score® test to help guide their treatment choices with their physician. Do you know how genomic testing works? | Exact Sciences | Facebook

268K views · 254 reactions | You are not alone. Join over 2 million people whose lives have been touched by GeneSight. | GeneSight | Facebook